✦ LIBER ✦

A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer

✍ Scribed by E. Eisenhauer; V. Zanagnolo; D. Cohn; R. Salani; D. O'Malley; G. Sutton; B. Cobb; M. Vaughan; J. Fowler; L. Copeland

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of gemcitabine, carbopl

✍ Eisenhauer, Eric L.; Zanagnolo, Vanna; Cohn, David E.; Salani, Ritu; O'Malley, D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 430 KB

A phase II study of gemcitabine plus car

✍ M.F. Kose; J. Sufliarsky; S. Beslija; P. Saip; G. Tulunay; K. Krejcy; T. Minarik 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Combination gemcitabine, platinum, and b

✍ Debra L. Richardson; Floor J. Backes; Leigh G. Seamon; Vanna Zanagnolo; David M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 205 KB

NICE guidance on bevacizumab in combinat

✍ Pinilla-Dominguez, Pilar; Richardson, Joanna; Robertson, Janet; Adam, Jane 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 52 KB

Phase II study of gemcitabine in recurre

✍ Giuseppe D’Agostino; Frederic Amant; Patrick Berteloot; Giovanni Scambia; Ignace 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase II Study of Gemcitabine and Doceta

✍ Garcia, Agustin A.; Yessaian, Anne; Pham, Huyen; Facio, Grace; Muderspach, Laila 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 177 KB